Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

(PLASTIC-3) [18F]FAPI-PET/CT and Laparoscopy in STagIng advanced gastric Cancer – a multicenter prospective study Recruiting

2024-513255-32-00 Advanced gastric cancer 10 2025-07-03
AZALOX Study: Safety and Efficacy of PXS-5505 with 5-Azacitidine in MDS and CMML Patients Recruiting

2024-517237-40-00 Myelodysplastic Neoplasms (MDS) and Chronic Myelomonocy 8 2025-07-03
Master protocol of TCR-modified T cell therapy targeting HLA-restricted KRAS antigen administered in adult patients with metastatic or local… Recruiting

2024-513900-32-00 Pancreatic Ductal Adenocarcinoma 7 2025-07-03
A Trial of a novel agent in participants with previously treated Immunoglobulin Light-Chain (AL) Amyloidosis Recruiting

2024-519191-90-00 Immunoglobulin Light-Chain (AL) Amyloidosis 4 2025-07-02
Study of the treatment of patients with non-small cell lung cancer with metastasis with Cemiplimab and subsequent treatment with Cemiplimab … Recruiting

2024-518812-38-00 Non-small cell lung cancer (NSCLC) 4 2025-07-02
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Patients Treated for Blood Cancers Recruiting

2024-518829-15-00 previously untreated chronic lymphocytic leukemia (CLL) 9 2025-07-02
A clinical study of patritumab deruxtecan (HER3-DXd) in children with cancer (MK-9999-01C) Recruiting

2024-518771-66-00 Hepatoblastoma, Rhabdomyosarcoma 9 2025-07-01
A Phase 1b Study of JNJ-78278343, a T-cell Redirecting Agent Targeting Human Kallikrein 2 (KLK2), in Combination with either JNJ-63723283 (c… Recruiting

2022-503132-14-00 Metastatic Prostate Cancer 3 2025-06-30
A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) i… Recruiting

2024-516633-12-00 Locally advanced/ metastatic gastroesophageal junction 5 2025-06-30
Evaluating ivonescimab as a potential treatment for pleural mesothelioma patients whose cancer has returned after previous immunotherapy and… Recruiting

2024-519052-82-00 pleural mesothelioma 4 2025-06-30
Phase I, Open-label, Single-center, Dose Escalation Study to Assess Safety and Tolerability of anti-CD19 CAR-T Cells in Patients with B-cell… Recruiting

2024-519318-30-00 non-Hodgkin Lymphomas Subtypes: DLBCL - ORPHA: 544 Ag 1 2025-06-25
RR001, a cell-based gene therapy administered in combination with chemotherapy for the treatment of patients with locally advanced pancreati… Recruiting

2024-516019-26-00 Ductal adenocarcinoma of pancreas 7 2025-06-25
Pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulvar cancer not amenab… Recruiting

2024-515646-16-00 Recurrent, persistent, metastatic or locally advanced v 4 2025-06-24
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma (ADCElerate 1) Recruiting

2024-516900-41-00 Soft Tissue Sarcoma 7 2025-06-24
Comparison of the effects of prophylactic administration of Apixaban on thrombin generation in patients with de novo multiple myeloma and pa… Recruiting

2024-515329-27-00 Thromboembolism prophylaxis 6 2025-06-24
A Phase I dose finding study of MB-CART2219.1 targeting CD19/CD22 in adult and pediatric patients with relapsed/refractory B-cell malignanci… Recruiting

2024-516838-35-00 Patients with relapsed/refractory Lymphoma or ALL aged 1 2025-06-23
Phase 3 Study of I-DXd Versus Docetaxel in mCRPC Recruiting

2024-517423-40-00 Metastatic Castration-Resistant Prostate Cancer 5 2025-06-23
Phase I Study of PM534 to Patients with Advanced Solid Tumors Recruiting

2024-519013-57-00 Advances solid tumors 9 2025-06-23
Master Protocol of Novel Study Interventions and Combinations in Participants with Colorectal Cancer Recruiting

2024-518469-84-00 Colorectal cancer 4 2025-06-20
A First-in-Human phase 1, open-label, two-stage, randomized trial to assess the safety, tolerability, and biodistribution of [177Lu]Lu-ABY-2… Recruiting

2024-518360-13-00 HER2-positive metastatic breast cancer 1 2025-06-18
A Phase 1/2a Study of BMS-986507 (BL-B01D1) in Adult Participants with Advanced Solid Tumors Recruiting

2024-514947-27-00 Advance solid tumors 9 2025-06-18
Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation (alloSCT) In Patients with Acute Myeloid Leu… Recruiting

2023-509055-14-00 myelodysplastic neoplasia (MDS) 4 2025-06-17
A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescent… Recruiting

2023-509723-41-01 Refractory/ relapsed acute lymphoblastic leukemia in ch 3 2025-06-16
Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting

2024-515764-31-00 Non-small cell lung cancer 10 2025-06-13